RESUMEN
Ochratoxin A (OTA), a mycotoxin mostly produced by Aspergillus ochraceus and Penicillium verrucosum, is a worldwide contaminant of food and feedstuff. OTA is nephrotoxic and a renal carcinogen in rodents. The underlying molecular and cellular mechanisms by which OTA exhibits its toxicity have yet not been fully clarified. In the present study the effects of ochratoxin A on the activity of redox-regulated transcription factors, antioxidant enzymes, as well as glutathione-S-transferase (GST) have been studied in cultured kidney tubulus cells (LLC-PK1). Confluent LLC-PK1 cells were incubated with increasing concentrations of OTA for 24h. OTA decreased SOD activity and enhanced intracellular levels of reactive oxygen species (ROS) as measured by flow cytometry. Furthermore OTA resulted in a down-regulation of GST mRNA and activity levels. Lower GST levels were accompanied by a decreased transactivation of activator protein-1 (AP-1) and NF-E2-related factor-2 (Nrf2), which mediate GST gene transcription. Present data indicate that enhanced ROS production and an impairment of GST activity, possibly due to an AP-1 and Nrf2 dependent signal transduction pathway, may be centrally involved in OTA induced nephrotoxicity.
Asunto(s)
Antioxidantes/metabolismo , Carcinógenos/toxicidad , Glutatión Transferasa/metabolismo , Túbulos Renales/metabolismo , Ocratoxinas/toxicidad , Factores de Transcripción/metabolismo , Animales , Células Cultivadas , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Genes Reporteros , Túbulos Renales/efectos de los fármacos , Túbulos Renales/enzimología , Células LLC-PK1 , Factor 2 Relacionado con NF-E2/biosíntesis , Factor 2 Relacionado con NF-E2/genética , Oxidación-Reducción , ARN Mensajero/biosíntesis , ARN Mensajero/genética , Especies Reactivas de Oxígeno/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Transducción de Señal/efectos de los fármacos , Porcinos , Factor de Transcripción AP-1/biosíntesis , Factor de Transcripción AP-1/efectos de los fármacosRESUMEN
Photodynamic therapy is a promising antitumor treatment modality approved for the management of both early and advanced tumors. The mechanisms of its antitumor action include generation of singlet oxygen and reactive oxygen species that directly damage tumor cells and tumor vasculature. A number of mechanisms seem to be involved in the protective responses to PDT that include activation of transcription factors, heat shock proteins, antioxidant enzymes and antiapoptotic pathways. Elucidation of these mechanisms might result in the design of more effective combination strategies to improve the antitumor efficacy of PDT. Using DNA microarray analysis to identify stress-related genes induced by Photofrin-mediated PDT in colon adenocarcinoma C-26 cells, we observed a marked induction of heme oxygenase-1 (HO-1). Induction of HO-1 with hemin or stable transfection of C-26 with a plasmid vector encoding HO-1 increased resistance of tumor cells to PDT-mediated cytotoxicity. On the other hand, zinc (II) protoporphyrin IX, an HO-1 inhibitor, markedly augmented PDT-mediated cytotoxicity towards C-26 and human ovarian carcinoma MDAH2774 cells. Neither bilirubin, biliverdin nor carbon monoxide, direct products of HO-1 catalysed heme degradation, was responsible for cytoprotection. Importantly, desferrioxamine, a potent iron chelator significantly potentiated cytotoxic effects of PDT. Altogether our results indicate that HO-1 is involved in an important protective mechanism against PDT-mediated phototoxicity and administration of HO-1 inhibitors might be an effective way to potentiate antitumor effectiveness of PDT.
Asunto(s)
Hemo-Oxigenasa 1/fisiología , Fotoquimioterapia/efectos adversos , Animales , Monóxido de Carbono/química , Monóxido de Carbono/farmacología , Quelantes/farmacología , Éter de Dihematoporfirina/química , Hemo/química , Hemo-Oxigenasa 1/metabolismo , Humanos , Hierro/farmacología , Ratones , Neoplasias/patología , Análisis de Secuencia por Matrices de Oligonucleótidos , Oxígeno/metabolismo , Especies Reactivas de OxígenoAsunto(s)
Factores de Crecimiento Endotelial/biosíntesis , Linfocinas/biosíntesis , Óxido Nítrico/biosíntesis , Regulación hacia Arriba , Angioplastia de Balón , Animales , Factores de Crecimiento Endotelial/genética , Inducción Enzimática , Regulación de la Expresión Génica , Humanos , Linfocinas/genética , Óxido Nítrico Sintasa/biosíntesis , Óxido Nítrico Sintasa/genética , Ratas , Factor A de Crecimiento Endotelial Vascular , Factores de Crecimiento Endotelial VascularRESUMEN
OBJECTIVES: The purpose of the study was to investigate the role of nitric oxide (NO) in monocyte-endothelial interaction by augmenting NO release via transfection of human endothelial cells (ECs) with EC NO synthase (eNOS) DNA. BACKGROUND: Enhancement of NO synthesis by L-arginine or shear stress reduces endothelial adhesiveness for monocytes and inhibits atherogenesis. To elucidate further the underlying mechanism, we augmented NO synthase expression by transfection of human EC. METHODS: Liposome-mediated transfection of EC was performed with a plasmid construct containing the gene encoding eNOS. Expression of eNOS was confirmed by reverse transcription-polymerase chain reaction (RT-PCR). Endothelial cells were exposed to human monocytoid cells, and adherent cells were quantitated using a computer-assisted program. Nitric oxide was measured by chemiluminescence. RESULTS: The NO levels were not different in EC that were either not transfected, transfected with beta-gal or liposomes only. The nitric oxide synthase (NOS) transfection increased NO release by +60% (n = 6), which increased further when EC were stimulated by shear stress (24 h) by +137% (n = 5) as compared with untransfected, unstimulated EC (both p < 0.05). The RT-PCR revealed diminished monocyte chemotactic protein-1 (MCP-1) expression in eNOS transfected EC. There was an inverse relation between NO levels and monocyte binding (r = -0.5669, p < 0.002). Stimulation of EC with tumor necrosis factor-alpha (TNF-alpha; 250 U/ml) led to a decrease in NO synthesis, and an increase in monocyte binding. Cells transfected with NOS were resistant to both effects of TNF-alpha. CONCLUSIONS: Endothelial cells transfected with eNOS synthesize an increased amount of NO; this is associated with diminished MCP-1 expression and monocyte-endothelial binding. The reduction in monocyte-endothelial binding persists even after cytokine stimulation.
Asunto(s)
Endotelio Vascular/fisiología , Técnicas de Transferencia de Gen , Óxido Nítrico Sintasa/genética , Óxido Nítrico/metabolismo , Adhesión Celular/genética , Línea Celular , Quimiocina CCL2/metabolismo , Regulación de la Expresión Génica/fisiología , Humanos , Liposomas , Monocitos/fisiología , TransfecciónRESUMEN
Induction of heme oxygenase-1 (HO-1) expression can be achieved by stimulation with cobalt protoporphyrin (CoPPIX) or cobalt chloride (CoCl2). HO-1 has been recently implicated in regulation of angiogenesis and CoCl2 is known to potently activate hypoxia inducible factor-1 (HIF-1) transcription factor, a key regulator of angiogenic response in hypoxia. Here we determined the effect of CoPPIX and CoCl2 on the expression of vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8), the two major angiogenic mediators, in human microvascular endothelial cells (HMEC-1). CoPPIX induced HO-1 expression and strongly enhanced VEGF and IL-8 synthesis, through the activation of VEGF and IL-8 promoters. Inhibition of HO activity by SnPPIX decreased VEGF production, while, interestingly, it did not affect IL-8. CoCl2 activated hypoxia-responsive element (HRE) and consequently VEGF generation via the enhancement of production of reactive oxygen species (ROS). On the other hand, CoCl2 did not influence IL-8 expression, while CoPPIX did not induce ROS elevation neither it affected HRE activity in VEGF promoter. Our data show that although both CoCl2 and CoPPIX induce HO-1, the influence of CoCl2 on VEGF does not involve HO-1 and is HIF-1-dependent, while the effect of CoPPIX does not involve HIF-1 but relies on HO-1.
Asunto(s)
Cobalto/farmacología , Células Endoteliales/efectos de los fármacos , Regulación de la Expresión Génica/efectos de los fármacos , Hemo-Oxigenasa 1/metabolismo , Interleucina-8/biosíntesis , Neovascularización Fisiológica/genética , Protoporfirinas/farmacología , Factor A de Crecimiento Endotelial Vascular/biosíntesis , Células Cultivadas , Células Endoteliales/metabolismo , Hemo-Oxigenasa 1/genética , Humanos , Neovascularización Fisiológica/efectos de los fármacosRESUMEN
OBJECTIVE: Vascular endothelial growth factor (VEGF) induces the release of nitric oxide (NO) from endothelial cells. There is also limited data suggesting that NO may enhance VEGF generation. METHODS: To further investigate this interaction, we examined the effect of exogenous and endogenous NO on the synthesis of VEGF by rat and human vascular smooth muscle cells (VSMC) by exposing cells to exogenous NO donors, or to genetic augmentation of eNOS or iNOS. RESULTS: NO-donors potentiated by 2-fold the generation of VEGF protein by rat or human VSMC. Similarly, rat or human VSMC transiently transfected with plasmid DNA encoding eNOS or iNOS, synthesized up to 3-fold more VEGF than those transfected with control plasmid DNA, an effect which was reversed after treatment with the NOS antagonist L-NAME. Rat VSMC stably transfected with pKeNOS plasmid, constitutively produced NO and released high concentrations of VEGF. In these cells, L-NAME significantly reduced NO synthesis and decreased VEGF generation. The VEGF protein produced by NOS-transfected VSMC was biologically active, as conditioned media harvested from these cells increased endothelial cell proliferation. CONCLUSION: These studies reveal that NO derived from NO-donors or generated by NOS within the cells, upregulates the synthesis of VEGF in vascular smooth muscle cells. Administration of NO donors, or augmentation of endogenous NO synthesis, may be an alternative approach in therapeutic angiogenesis.
Asunto(s)
Factores de Crecimiento Endotelial/biosíntesis , Linfocinas/biosíntesis , Músculo Liso Vascular/enzimología , Donantes de Óxido Nítrico/farmacología , Óxido Nítrico Sintasa/genética , Transfección , Análisis de Varianza , Animales , Células Cultivadas , DEET/farmacología , Factores de Crecimiento Endotelial/genética , Humanos , Linfocinas/genética , Molsidomina/análogos & derivados , Molsidomina/farmacología , Óxido Nítrico Sintasa/metabolismo , Óxido Nítrico Sintasa de Tipo II , Óxido Nítrico Sintasa de Tipo III , Penicilamina/análogos & derivados , Penicilamina/farmacología , ARN Mensajero/análisis , Ratas , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factor A de Crecimiento Endotelial Vascular , Factores de Crecimiento Endotelial VascularRESUMEN
Sarcoidosis is a multi-organ disease in which affected tissues are invaded with non-necrotizing granulomatous structures, mostly consisted of T helper 1 (Th1) cells and multinucleate giant cells. However, the etiology and pathogenesis of sarcoidosis is not known and the diagnosis is usually based on clinical examination involving radiography and histopathological analysis of biopsies of affected organs. Although the knowledge on the molecular background of sarcoidosis is limited, it seems that the important pathways involve transforming growth factor-ß (TGF-ß) and JAK/STAT, which may influence the interferon-γ (IFN-γ)-mediated signaling. Additionally, recently the role of microRNAs (miRNAs), the small non-coding RNA molecules, has been emphasized in different pathological conditions including autoimmune diseases. This review summarizes the current knowledge on the molecular pathways in the pathogenesis of sarcoidosis with a special emphasis on cytokines and miRNAs controlling immune cells proliferation and differentiation. Moreover, the possible role of T regulatory cells (CD4(+) CD25(+) FoxP3(+)) in this disease has been discussed.
Asunto(s)
Inflamación/patología , MicroARNs/genética , Sarcoidosis Pulmonar/fisiopatología , Animales , Diferenciación Celular/fisiología , Proliferación Celular/fisiología , Citocinas/metabolismo , Humanos , Inflamación/genética , Sarcoidosis Pulmonar/genética , Linfocitos T Reguladores/metabolismoRESUMEN
Mouse and human induced pluripotent stem cells (iPSCs) may represent a novel approach for modeling diabetes. Taking this into consideration, the aim of this study was to generate and evaluate differentiation potential of iPSCs from lep(db/db) (db/db) mice, the model of diabetes type 2 as well as from patients with Maturity Onset Diabetes of the Young 3 (HNF1A MODY). Murine iPSC colonies from both wild type and db/db mice were positive for markers of pluripotency: Oct3/4A, Nanog, SSEA1, CDy1 and alkaline phosphatase and differentiated in vitro and in vivo into cells originating from three germ layers. However, our results suggest impaired differentiation of db/db cells into endothelial progenitor-like cells expressing CD34 and Tie2 markers and their reduced angiogenic potential. Human control and HNF1A MODY reprogrammed cells also expressed pluripotency markers: OCT3/4A, SSEA4, TRA-1-60, TRA-1-81, formed embryoid bodies (EBs) and differentiated into cells of three germ layers. Additionally, insulin expressing cells were obtained from those partially reprogrammed cells with direct as well as EB-mediated differentiation method. Our findings indicate that disease-specific iPSCs may help to better understand the mechanisms responsible for defective insulin production or vascular dysfunction upon differentiation toward cell types affected by diabetes.
Asunto(s)
Diabetes Mellitus Tipo 2/patología , Células Madre Pluripotentes Inducidas/metabolismo , Adulto , Animales , Biomarcadores , Diferenciación Celular , Células Cultivadas , Cuerpos Embrioides/metabolismo , Células Progenitoras Endoteliales/metabolismo , Femenino , Proteínas de Homeodominio/metabolismo , Humanos , Antígeno Lewis X/metabolismo , Masculino , Ratones Endogámicos C57BL , Ratones Obesos , Persona de Mediana Edad , Proteína Homeótica Nanog , Proteínas Nucleares/metabolismo , Factor 3 de Transcripción de Unión a Octámeros/metabolismoRESUMEN
Nitric oxide (NO) generated by inducible NO synthase (iNOS) enhances vascular endothelial growth factor (VEGF) synthesis in vascular smooth muscle cells (VSMC) and both NO and modified low density lipoprotein (LDL) augment VEGF production in macrophages. Oxidized LDL (oxLDL) are known inhibitors of NO generation in the cells of vascular wall. As the relationship between VEGF, iNOS and oxLDL has not been well elucidated, we studied the effect of two main components of oxLDL, 7-ketocholesterol (7-Kchol) and lysophosphatidylcholine (LPC), on VEGF and NO synthesis in rat VSMC and on VEGF synthesis in human VSMC. Both LPC and 7-Kchol significantly augmented VEGF production in rat and human VSMC. Increase in VEGF generation was related to the activation of VEGF promoter by both 7-Kchol and LPC and enhancement of VEGF mRNA transcription. In rat, VSMC IL-1beta-induced NO generation and enhanced VEGF synthesis. 7-Kchol decreased rat iNOS promoter activity, iNOS expression and NO generation, but it did not impair IL-1beta-induced VEGF synthesis. LPC did not significantly influence IL-1beta-induced NO production in rat VSMC and VEGF synthesis was significantly enhanced by combined treatment with IL-1beta and LPC in comparison to the effect of either compound alone. The results indicate that VEGF and NO synthesis in VSMC can be modulated by oxLDL. Those interactions might have an effect on the plaque growth and might be of relevance for the physiology of vascular wall cells.
Asunto(s)
Factores de Crecimiento Endotelial/biosíntesis , Cetocolesteroles/farmacología , Linfocinas/biosíntesis , Linfocinas/efectos de los fármacos , Lisofosfatidilcolinas/farmacología , Óxido Nítrico/metabolismo , Análisis de Varianza , Animales , Humanos , Músculo Liso Vascular/citología , Músculo Liso Vascular/metabolismo , Óxido Nítrico/análisis , Probabilidad , ARN Mensajero/análisis , Ratas , Valores de Referencia , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Factor A de Crecimiento Endotelial Vascular , Factores de Crecimiento Endotelial VascularRESUMEN
The morphological changes were observed in the spleen and the thymus of the yellow-bellied toad, Bombina variegata, kept under standard laboratory conditions. The mean splenic weights of toads studied soon after capture in July and September were 16.0 mg and 17.7 mg, respectively. In contrast, the mean splenic weights significantly decreased in animals maintained in the laboratory from July till September (to 11.6 mg) and from July till December (to 6.8 mg). In the spleen of toads kept in the laboratory the lymphocyte aggregations were diminished in the white pulp while the amount of connective tissues increased both in the white and in the red pulps. Melano-macrophages were more abundant in the red pulp of toads kept in the laboratory than in freshly collected ones. The thymuses of toads kept in the laboratory were decreased in size and depleted of the majority of their cortical lymphocytes. It is suggested that the morphological changes of the yellow-bellied toad lymphoid organs might be the results of stressful laboratory conditions and lower antigenic stimulation in the laboratory than in nature.
Asunto(s)
Anuros/anatomía & histología , Bazo/anatomía & histología , Timo/anatomía & histología , Animales , Anuros/inmunología , Dieta/efectos adversos , Ambiente , Femenino , Masculino , Bazo/inmunología , Estrés Fisiológico/inmunología , Estrés Fisiológico/patología , Timo/inmunologíaRESUMEN
Plasma diagnostic studies have been carried out on the discharge source of a commercial glow discharge quadrupole mass spectrometer. Plasma parameters were determined using an electrostatic probe with the objective of determining the dependence (if any) of these parameters on the voltage placed on an auxiliary electrode immersed in the plasma. The biased electrode utilized in this study was the sampling orifice element itself. Our results indicate that, for positive orifice voltages with respect to the grounded anode, variations in the plasma potential and ion energy can be correlated directly to the bias placed on the sampling orifice. The dependence of the electron temperature on this parameter is observed to be more complex in nature, and electron number densities show little significant variation with respect to sampling orifice bias. In addition, increased orifice voltages result in an increase in the ion signal intensity measured with the mass spectrometer. Based on the results obtained here, we feel that this increase is due primarily to an increase in ion transmission to the quadrupole arising from the increased ion energy.(J Am Soc Mass Spectrom 1990, 1, 448-454).
RESUMEN
Peroxisome proliferator-activated receptors-gamma (PPARgamma) are ligand-inducible transcription factors of the nuclear hormone receptor superfamily. We examined the effect of PPARgamma activation on the generation of vascular endothelial growth factor (VEGF), one of the major angiogenic agents. Rat vascular smooth muscle cells (VSMC) and murine macrophages RAW264.7 were incubated for 24 h with PPARgamma activators: prostaglandin J2 and ciglitazone. PPARgamma were expressed in VSMC and RAW cells and their activity was upregulated in the presence of PGJ2 and ciglitazone. Incubation of the cells with PPARgamma activators significantly augmented the release of VEGF protein into the media, both in resting and in IL-1beta- or LPS-stimulated cultures. The higher protein generation was connected with the increased expression of mRNA and transcriptional activation of VEGF promoter. We conclude that the activation of PPARgamma upregulates the generation of VEGF and may be involved in the regulation of angiogenesis.
Asunto(s)
Factores de Crecimiento Endotelial/metabolismo , Endotelio Vascular/metabolismo , Linfocinas/metabolismo , Macrófagos/metabolismo , Músculo Liso/citología , Músculo Liso/metabolismo , Prostaglandina D2/análogos & derivados , Receptores Citoplasmáticos y Nucleares/metabolismo , Tiazolidinedionas , Factores de Transcripción/metabolismo , Animales , Antineoplásicos/farmacología , Línea Celular , Células Cultivadas , Relación Dosis-Respuesta a Droga , Hipoglucemiantes/farmacología , Interleucina-1/metabolismo , Ligandos , Lipopolisacáridos/metabolismo , Ratones , Regiones Promotoras Genéticas , Prostaglandina D2/farmacología , ARN Mensajero/metabolismo , Ratas , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Tiazoles/farmacología , Activación Transcripcional , Transfección , Regulación hacia Arriba , Factor A de Crecimiento Endotelial Vascular , Factores de Crecimiento Endotelial VascularRESUMEN
The regulation of vascular wall homeostasis by nitric oxide (NO) generated by endothelium is being intensively studied. In the present paper, the involvement of NO in the vascular endothelial growth factor (VEGF), insulin or leptin-stimulated proliferation of human endothelial cells (HUVEC) was measured by [3H]thymidine or bromodeoxyuridine incorporation. VEGF and insulin, but not leptin, increased NO generation in HUVEC, as detected with ISO-NO electrode. Proliferation of HUVEC induced by leptin was not changed or was higher in the presence of N(omega)-nitro-L-arginine methyl ester (L-NAME) a nitric oxide synthase (NOS) inhibitor. In contrast, L-NAME blunted the proproliferative effect of VEGF and insulin. Furthermore, we demonstrated that, in human arterial smooth muscle cells (hASMC) transfected with endothelial NOS (eNOS) gene, the generation of biologically active VEGF protein was NO-dependent. Inhibition of NO generation by L-NAME decreased the synthesis of VEGF protein and attenuated HUVEC proliferation induced by conditioned media from transfected hASMC. Endothelium-derived NO seems to participate in VEGF and insulin, but not leptin, mitogenic activity. Additionally, the small amounts of NO released from endothelial cells, as mimicked by eNOS transfection into hASMC, may activate generation of VEGF in sub-endothelial smooth muscle cells, leading to increased synthesis of VEGF protein necessary for turnover and restitution of endothelial cells.
Asunto(s)
Factores de Crecimiento Endotelial/farmacología , Endotelio Vascular/citología , Endotelio Vascular/efectos de los fármacos , Insulina/farmacología , Linfocinas/farmacología , Óxido Nítrico/fisiología , División Celular/efectos de los fármacos , División Celular/fisiología , Células Cultivadas , Medios de Cultivo Condicionados , Factores de Crecimiento Endotelial/biosíntesis , Endotelio Vascular/fisiología , Inhibidores Enzimáticos/farmacología , Humanos , Leptina/farmacología , Linfocinas/biosíntesis , Mitógenos/farmacología , Músculo Liso Vascular/citología , Músculo Liso Vascular/efectos de los fármacos , Músculo Liso Vascular/fisiología , NG-Nitroarginina Metil Éster/farmacología , Óxido Nítrico Sintasa/antagonistas & inhibidores , Óxido Nítrico Sintasa/genética , Óxido Nítrico Sintasa de Tipo III , Timidina/metabolismo , Transfección , Factor A de Crecimiento Endotelial Vascular , Factores de Crecimiento Endotelial VascularRESUMEN
The aim of this study was to optimize the conditions for in vitro lipotransfection of rat vascular smooth muscle cells (VSMC) with bacterial beta-galactosidase gene and bovine endothelial nitric oxide synthase (ecNOS) gene. Transfection efficiency of four liposomes: Transfectam, Lipofectin, Unifectin-10, and Maxifectin was compared. The best results (efficiency 1-5%) were obtained with Maxifectin, when transfections were performed in VSMC cultures being at 50% confluency, with 1 microg DNA and 10 microl liposome per well, and when the liposome/DNA complexes were coincubated with the cells for 24 h. This method allowed detection of the transgene activity 12 h after the beginning of the transfection, with maximum values between the second and fourth days. The expression of the potentially therapeutic ecNOS gene was evidenced by confirmation of ecNOS mRNA generation, indirect detection of active ecNOS protein and by measurement of nitrite ion accumulation in the medium from the transfected cell cultures.
Asunto(s)
Músculo Liso Vascular/enzimología , Óxido Nítrico Sintasa/genética , Transfección/métodos , beta-Galactosidasa/genética , Animales , Aorta Torácica/citología , Aorta Torácica/enzimología , Bovinos , Medios de Cultivo , Dihidrolipoamida Deshidrogenasa/metabolismo , Regulación Enzimológica de la Expresión Génica , Músculo Liso Vascular/citología , Óxido Nítrico Sintasa de Tipo III , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas , Reacción en Cadena de la Polimerasa de Transcriptasa InversaRESUMEN
PPARgamma is a transcription factor of nuclear receptor superfamily, involved in the regulation of inflammation. We investigated the influence of PPARgamma-ligands, 15-deoxy-delta12,14 prostaglandin-J2 (15d-PGJ2), and ciglitazone, on the generation of interleukin-8 (IL-8) by the human microvascular endothelial cell line (HMEC- 1). Expression of PPARgamma in HMEC-1 was confirmed by RT-PCR. Both PPARgamma-ligands tested induced the activation of PPAR, but the potency of ciglitazone was higher, as evidenced by luciferase assay. Resting HMEC-1 released about 150 pg/ml of IL-8 protein. Treatment with LPS increased the IL-8 secretion up to 1 ng/ml. 15d-PGJ2 potently and dose-dependently increased both the steady-state and LPS-induced generation of IL-8 mRNA and IL-8 protein. In contrast, neither basal nor LPS-elicited expression of IL-8 was influenced by ciglitazone. We conclude, that 15d-PGJ2 is a potent inducer of IL-8 production and can be a mediator of inflammatory response, but this effect is independent of PPARgamma activation.
Asunto(s)
Endotelio Vascular/efectos de los fármacos , Interleucina-8/biosíntesis , Prostaglandina D2/análogos & derivados , Prostaglandina D2/farmacología , Receptores Citoplasmáticos y Nucleares/metabolismo , Tiazolidinedionas , Factores de Transcripción/metabolismo , Línea Celular , Supervivencia Celular , Ensayo de Cambio de Movilidad Electroforética , Endotelio Vascular/metabolismo , Humanos , Interleucina-8/genética , Interleucina-8/metabolismo , Ligandos , FN-kappa B/metabolismo , ARN Mensajero/genética , ARN Mensajero/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Tiazoles/farmacología , Transfección , Regulación hacia Arriba/efectos de los fármacosRESUMEN
Several studies have already demonstrated that oxidized- LDL decreases nitric oxide (NO) generation by cytokine-stimulated macrophages. However, the mechanisms of such an inhibition have not been yet elucidated. NO generation by inducible nitric oxide synthase (iNOS) is dependent on the presence of cofactors for NO generation, tetrathydrobiopterin (BH4) among them. The NO generation by these cells is also regulated by some endogenous inhibitors, like TGF-beta. Therefore, the aim of our recent study was to investigate the influence of ox-LDL on the expression of iNOS and GTP cyclohydrolase I (GTP-CH I), the key enzyme involved in the BH4 synthesis as well as the ox-LDL effect on TGF-beta expression in rat macrophages stimulated with IFNgamma (250 U/ml) and LPS (500 ng/ml). Macrophages, activated in this way, express iNOS, GTP-CH I, and TGF-beta mRNA. This expression was inhibited when the macrophages were preincubated for 24 hours with ox-LDL (100 microg/ml). Quantitative PCR revealed about 10-fold inhibition of iNOS gene expression by ox-LDL. As a consequence of down-regulation of iNOS and GTP-CH I genes, almost 3-fold diminished generation of NO2- by rat macrophages was observed. An inhibition of the TGFbeta mRNA expression was also found. Our studies indicate that decreased NO generation by ox-LDL treated macrophages may be the result of the diminished expression of both iNOS and GTP-CH I genes. This effect may be mediated by the activity of certain endogenous inhibitors of gene expression, however, our studies exclude the TGF-beta as a candidate for this activity.
Asunto(s)
GTP Ciclohidrolasa/antagonistas & inhibidores , Lipoproteínas LDL/farmacología , Macrófagos Peritoneales/efectos de los fármacos , Macrófagos Peritoneales/metabolismo , Óxido Nítrico Sintasa/antagonistas & inhibidores , Factor de Crecimiento Transformador beta/antagonistas & inhibidores , Animales , Células Cultivadas , GTP Ciclohidrolasa/biosíntesis , GTP Ciclohidrolasa/genética , Expresión Génica/efectos de los fármacos , Humanos , Interferón gamma/farmacología , Lipopolisacáridos/farmacología , Macrófagos Peritoneales/enzimología , Óxido Nítrico/antagonistas & inhibidores , Óxido Nítrico/biosíntesis , Óxido Nítrico Sintasa/biosíntesis , Óxido Nítrico Sintasa/genética , Óxido Nítrico Sintasa de Tipo II , ARN Mensajero/aislamiento & purificación , Ratas , Factor de Crecimiento Transformador beta/biosíntesis , Factor de Crecimiento Transformador beta/genéticaRESUMEN
The generation of nitric oxide is regulated by several factors, including the substrates and cofactors supplementation. Decreased expression and activity of nitric oxide synthase as well as diminished amount of L-arginine or enzyme cofactors results in the inhibition of nitric oxide generation in vascular wall cells. GTP cyclohydrolase 1 is a key enzyme involved in the synthesis of tetrahydrobiopterin, one of the most important cofactors of NO synthases. We have demonstrated that oxidized LDL inhibit not only inducible nitric oxide synthase gene expression but also GTP cyclohydrolase I gene expression in interleukin-1 beta activated rat vascular smooth muscle cells in vitro. It is postulated that diminished availability of tetrahydrobiopterin may additionally impair the generation of nitric oxide in atherosclerosis.
Asunto(s)
GTP Ciclohidrolasa/biosíntesis , Lipoproteínas LDL/farmacología , Músculo Liso Vascular/efectos de los fármacos , Óxido Nítrico Sintasa/biosíntesis , Animales , Células Cultivadas , GTP Ciclohidrolasa/genética , Regulación de la Expresión Génica/efectos de los fármacos , Interleucina-1/antagonistas & inhibidores , Músculo Liso Vascular/enzimología , Óxido Nítrico Sintasa/genética , Óxido Nítrico Sintasa de Tipo II , ARN Mensajero/biosíntesis , RatasRESUMEN
The primitive anuran amphibian, the yellow-bellied toad, Bombina variegata, possesses the spleen with a large white pulp, containing the immune-complex-trapping-cells (ICTCs). The handling of immunologically different substances in the spleen of B. variegata was investigated. Adult toads were injected into dorsal lymph sacs with a mixture of rabbit peroxidase-antiperoxidase, FITC-Ficoll and latex beads. Two hours after injection antigens were found in the blood vessels of the spleen where some cells had also PAP on their surface. At that time antigens also reached the white and the red pulps. Finally PAP was trapped on the surface of ICTCs in the white pulp and was phagocytized by the white and red pulp macrophages. FITC-Ficoll was detected in the red pulp macrophages while latex beads in macrophages of both compartments. The present study suggests that ICTCs are specialized in trapping only immune complexes.
Asunto(s)
Antígenos/inmunología , Anuros/inmunología , Bazo/inmunología , Animales , Fluoresceína-5-Isotiocianato , Técnicas para Inmunoenzimas , Inmunohistoquímica , Látex , Macrófagos/inmunología , Microscopía Electrónica , Microesferas , Fagocitosis , Bazo/citologíaRESUMEN
Delivery of DNA mixed with a degradable matrix carrier was supposed to improve transgene expression. Using a rabbit hind-limb ischemia model, we tested the angiogenic potency of plasmid encoding human vascular endothelial growth factor (pSG5-VEGF165) entrapped in fibrin sealant. Animals were injected intramuscularly with 500 microg of pSG5-VEGF165 or control plasmid, dissolved in saline (PBS) or fibrin glue. After 14 days, presence of delivered constructs and expression of transgene was confirmed in injected muscles of all animals. There were no significant differences in the levels of human VEGF mRNA and protein between VEGF-PBS and VEGF-fibrin groups (Mann-Whitney test). Accordingly, pSG5-VEGF165 regardless of the way of delivery, induced similar increases in capillary density within treated muscles (ANOVA). Control plasmid did not show any effects. In conclusion, injection of pSG5-VEGF165 into ischemic adductor muscle leads to synthesis of human VEGF and increases the number of capillaries. Fibrin carrier does not influence its angiogenic potential.
Asunto(s)
Factores de Crecimiento Endotelial/administración & dosificación , Factores de Crecimiento Endotelial/genética , Adhesivo de Tejido de Fibrina/administración & dosificación , Expresión Génica , Terapia Genética , Péptidos y Proteínas de Señalización Intercelular/administración & dosificación , Péptidos y Proteínas de Señalización Intercelular/genética , Isquemia/terapia , Linfocinas/administración & dosificación , Linfocinas/genética , Músculo Esquelético/irrigación sanguínea , Neovascularización Fisiológica/genética , Animales , Factores de Crecimiento Endotelial/inmunología , Femenino , Adhesivo de Tejido de Fibrina/inmunología , Expresión Génica/genética , Miembro Posterior , Inmunidad/efectos de los fármacos , Inmunidad/fisiología , Péptidos y Proteínas de Señalización Intercelular/inmunología , Linfocinas/inmunología , Masculino , Modelos Animales , Neovascularización Fisiológica/fisiología , Plásmidos/administración & dosificación , Plásmidos/genética , Plásmidos/inmunología , Conejos , Factor A de Crecimiento Endotelial Vascular , Factores de Crecimiento Endotelial VascularRESUMEN
Chronic myelogenous leukemia is characterized by an abnormal 22nd chromosome known as a Philadelphia chromosome, which can be detected in 95% of patients with CML. Molecular equivalent of this aberration is a BCR-ABL translocation resulting in chimeric gene formation. A BCR-ABL chimeric gene plays a key role in the hematopoietic cells proliferation regulation. RT-PCR can be used in diagnosis of CML, to detect chimeric BCR-ABL gene, and to reveal the type of translocation what could have prognostic importance, and in monitoring of minimal residual disease, confirming the eradication of pathological cells clone after treatment and identifying the group of patients with best prognosis and best overall survival. RT-PCR in monitoring of minimal residual disease after allo- or autologous hemopoietic cells transplantation can early reveal relapse of the disease. Detection of molecular relapse is an important prognostic factor and may implicate induction of treatment which should prevent haematological relapse of the disease.